Successful in silico discovery of novel nonsteroidal ligands for human sex hormone binding globulin

Journal of Medicinal Chemistry

Volumn 48, Issue 9, 2005, Pages 3203-3213

  Cherkasov, Artem ^a   Shi, Zheng ^a   Fallahi, Magid ^a   Hammond, Geoffrey L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXANE DERIVATIVE; LIGAND; NONSTEROIDAL LIGAND; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ARTICLE; AZOOSPERMIA; BINDING AFFINITY; COMPUTER MODEL; DRUG DESIGN; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STRUCTURE ACTIVITY RELATION;

ALGORITHMS; BIBENZYLS; BINDING SITES; BINDING, COMPETITIVE; BRIDGED COMPOUNDS; DRUG DESIGN; HUMANS; KETONES; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEURAL NETWORKS (COMPUTER); PROTEIN BINDING; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RADIOLIGAND ASSAY; SEX HORMONE-BINDING GLOBULIN; STEROIDS;

EID: 18244370519     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm049087f     Document Type: Article

References (43)

1. Hammond, G. L. Potential functions of plasma steroid-binding protein. Trends Endocrinol. Metab. 1995, 6, 298-304.
2. Joseph, D. R. Structure, function, and regulation of androgen-binding protein/sex hormone-binding globulin. Vitam. Horm. 1994, 49, 197-280.
3. Siiteri, P. K.; Murai, J. T.; Hammond, G. L.; Nisker, J. A.; Raymoure, W. J.; Kuhn, R. W. The serum transport of steroid hormones. Recent Prog. Horm. Res. 1982, 38, 457-510.
4. Nakhla, A. M.; Rosner, W. Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin. Endocrinology. 1996, 137, 4126-4129.
5. Nisker, J. A.; Hammond, G. L.; Davidson, B. J.; Frumar, A. M.; Takaki, N. K.; Judd, H. L.; Siiteri, P. K. Serum sex hormone-binding globulin capacity and the percentage of free estradiol in postmenopausal women with and without endometrial carcinoma. A new biochemical basis for the association between obesity and endometrial carcinoma. Am. J. Obstet. Gynecol. 1980, 138, 637-642.
6. Hogeveen, K. N.; Cousin, P.; Pugeat, M.; Dewailey, D.; Soudan, B.; Hammond, G. L. Human sex hormone-binding globulin variants associated with hyperandrogenism and ovarian dysfunction. J. Clin. Invest. 2002, 109, 973-981.
7. Anderson, D. C. Sex-hormone-binding globulin. Clin Endocrinol. 1974, 3, 69-96.
8. Van Pttelgergh, I.; Goemaere, S.; Zmierczak, H.; Kaufman, J. M. Perturbed sex steroid status in men with idiopathic osteoporosis and their sons. J. Cin. Endocrinol. Metab. 2004, 89, 4949-4953.
9. Rapuri, P. B.; Gallagher, J. C.; Haynatzki, G. Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women. J. Clin. Endocrinol. Metab. 2004, 89, 4954-4962.
10. Lindstedt, G.; Lundberg, P.-A.; Lapidus, L.; Lundgren, L.; Björntrop, P. Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden. Diabetes 1991, 40, 123-128.
11. Haffner, S. M.; Katz, M. S.; Stern, M. P.; Dunn, J. F. Association of decreased sex hormone binding globulin and cardiovascular risk factors. Arteriosclerosis 1989, 9, 136-143.
12. Virtual Screening for Bioactive Molecules; Böhm, H.-J., Schneider, G., Kubinyi, H., Mannhold, R., Timmerman, H., Eds.; Methods and Principles in Medicinal Chemistry; Wiley: New York, 2000.
13. Klebe, G. Virtual Screening: An Alternative or Complement to High Throughput Screening?; Kluwer: Dordrecht, The Netherlands, 2000.
14. Guner, O. F. Pharmacophore Perception, Development, and Use in Drug Design; IUL Biotechnology Series; International University Line: La Jolla, CA, 2000.
15. Cherkasov, A. "Inductive" Descriptors. 10 Successful Years in QSAR. Curr. Comput.-Aided Drug Des. 2005, 1, 21-42.
16. Cherkasov, A. Inductive QSAR Descriptors. Distinguishing Compounds with Antibacterial Activity by Artificial Neural Networks. Int. J. Mol. Sci., in press.
17. Cherkasov, A.; Jankovic, B. Application of "Inductive" QSAR Descriptors for Quantification of Antibacterial Activity of Cationic Polypeptides. Molecules 2004, 9, 1034-1052.
18. Schottner, M.; Gansser, D.; Siteller, K. M. Lignans interfering with 5 alpha-dihydrotestosterone binding to human sex hormone-binding globulin. J. Nat. Prod. 1997, 61, 119-121.
19. Newman, D. J.; Cragg, G. M.; Snader, K. M. Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 2003, 66, 1022-1037.
20. Westphal, U. Steroid-Protein Interaction II. Mongraphs in Endocrinology; Springer-Verlag: Berlin, 1986.
21. Xu, J.; Stevenson, J. Drug-like index: a new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci. 2000, 40, 1177-1187.
22. MOE: Molecular Operational Environment, version 2003.10; Chemical Computation Group Inc.: Montreal, Canada, 2004.
23. Catalyst, version 4.8; Accelrys Inc.: San Diego, CA, 2004.
24. Cherkasov, A. Inductive Electronegativity Scale. Iterative Calculation of Inductive Partial Charges. J. Chem. Inf. Comput. Sci. 2003, 43, 2039-2047.
25. Cherkasov, A. R.; Galkin, V. I.; Cherkasov, R. A. "Inductive" Electronegativity Scale. 2. "Inductive" Analog of Chemical Hardness. J. Mol. Struct.: THEOCHEM 2000, 497, 115-123.
26. Cherkasov, A. R.; Galkin, V. I.; Cherkasov, R. A. A New Approach to the Theoretical Estimation of Inductive Constants. J. Phys. Org. Chem. 1998, 11, 437-447.
27. Cherkasov, A. R.; Galkin, V. I.; Cherkasov, R. A. "Inductive" Electronegativity Scale. J. Mol. Struct: THEOCHEM 1999, 489, 43-46.
28. Asinex Gold Collection; Asinex Ltd.: Moscow, 2004.
29. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
30. Grishkovskaya, I.; Awakumov, G. V.; Hammond, G. L.; Catalano, M. G.; Muller, Y. A. Steroid ligands bind human sex hormone-binding globulin in specific orientations and produce distinct changes in protein conformation. J. Biol. Chem. 2002, 277, 32086-32093.
31. Awakumov, G. V.; Grishkovskaya, I.; Muller, Y. A.; Hammond, G. L. Crystal structure of human sex hormone-binding globulin in complex with 2-methoxyestradiol reveals the molecular basis for high affinity interactions with C-2 derivatives of estradiol. J. Biol. Chem. 2002, 277, 45219-45225.
32. Grishkovskaya, I.; Awakumov, G. V.; Hammond, G. L.; Muller, Y. A. Resolution of a disordered region at the entrance of the human sex hormone-binding globulin steroid-binding site. J. Mol. Biol. 2002, 318, 621-626.
33. Hammond, G. L.; Awakumov, G. V.; Muller, Y. A. Structure/function analyses of human sex hormone-binding globulin: effects of zinc on steroid-binding specificity. J. Steroid Biochem. Mol. Biol. 2003, 85, 195-200.
34. Awakumov, G. V.; Muller, Y. A.; Hammond, G. L. Steroid-binding specificity of human sex hormone-binding globulin is influenced by occupancy of a zinc-binding site. J. Biol. Chem. 2000, 275, 25920-25925.
35. Glide, version 2.7; Schrödinger Inc.: San Diego, CA, 2004.
36. Dechaud, H.; Ravard, C.; Claustrat, F.; de la Perriere, A. B.; Pugeat, M. Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 1999, 64, 328-334.
37. Hogert, J.; Zacharewski, T. R.; Hammond, G. L. Interactions between human plasma sex hormone-binding globulin and xenobiotic ligands. J. Steroid Biochem. Mol. Biol. 2000, 75, 167-176.
38. Rousseau, G. G.; Rolin Jacquemyns, C. F.; Sirett, D. A. N.; Huybrechts, M.; De Coen, J. L.; Quivy, J. I. Inhibition of steroid-protein interactions by dicyclohexane derivatives. J. Steroid Biochem. 1988, 31, 691-697.
39. Rousseau, G. G.; Quivy, J. I.; Kirchnoff, J.; Bui, X.-H.; Devis, R. Nonsteroidal compounds which bind epididymal androgen-binding protein but not the androgen receptor. Nature 1980, 284, 458-459.
40. SNNS: Stuttgart Neural Network Simulator, version 4.0; University of Stuttgart: Stuttgart, Germany, 1995.
41. Maestero; Schrödinger Inc.: San Diego, CA, 2004.
42. Halgren, T. A. Merck Molecular Force Field. I. Basis, Form, Scope, Parameterization and Performance of MMFF94. J. Comput. Chem. 1996, 17, 490-519.
43. Hammond, G. L.; Lahteenmaki, P. L. A versatile method for the determination of serum cortisol binding globulin and sex hormone binding globulin binding capacities. Clin. Chim. Acta 1983, 132, 101-110.